CoChat

Mitochondrial dynamics and quality control in Huntington's disease

Guedes-Dias, Pedro, Pinho, Brígida R., Soares, Tânia R., de Proença, João, Duchen, Michael R., Oliveira, Jorge M.A. · 2016 · Neurobiology of Disease
Cited by 113

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nbd.2015.09.008

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Research works printed but not linked: 80

  1. Amadoro, 2014, Morphological and bioenergetic demands underlying the mitophagy in post-mitotic neurons: the pink-parkin pathway, Front. Aging Neurosci., 6, 18, 10.3389/fnagi.2014.00018 · DOI · Paper page
  2. Ashrafi, 2015, PINK1- and PARK2-mediated local mitophagy in distal neuronal axons, Autophagy, 11, 187
  3. Aylward, 2011, Longitudinal change in regional brain volumes in prodromal huntington disease, J. Neurol. Neurosurg. Psychiatry, 82, 405, 10.1136/jnnp.2010.208264 · DOI · Paper page
  4. Baldo, 2013, Maintenance of basal levels of autophagy in huntington's disease mouse models displaying metabolic dysfunction, PLoS ONE, 8, e83050, 10.1371/journal.pone.0083050 · DOI
  5. Birsa, 2014, Lysine 27 ubiquitination of the mitochondrial transport protein Miro is dependent on serine 65 of the Parkin ubiquitin ligase, J. Biol. Chem., 289, 14569, 10.1074/jbc.M114.563031 · DOI · Paper page
  6. Bolanos, 2010, Glycolysis: a bioenergetic or a survival pathway?, Trends Biochem. Sci., 35, 145, 10.1016/j.tibs.2009.10.006 · DOI · Paper page
  7. Brustovetsky, 2003, Increased susceptibility of striatal mitochondria to calcium-induced permeability transition, J. Neurosci., 23, 4858, 10.1523/JNEUROSCI.23-12-04858.2003 · DOI · Paper page
  8. Burté, F., Carelli, V., Chinnery, P.F., Yu-Wai-Man, P., 2015. Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat. Rev. Neurol. 11, 11-24. · DOI · Paper page
  9. Chang, 2010, Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1, Ann. N. Y. Acad. Sci., 1201, 34, 10.1111/j.1749-6632.2010.05629.x · DOI · Paper page
  10. Chang, 2006, Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons, Neurobiol. Dis., 22, 388, 10.1016/j.nbd.2005.12.007 · DOI · Paper page
  11. Costa, 2010, Mitochondrial fission and cristae disruption increase the response of cell models of huntington's disease to apoptotic stimuli, EMBO Mol. Med., 2, 490, 10.1002/emmm.201000102 · DOI · Paper page
  12. Costa, 2012, Shaping the role of mitochondria in the pathogenesis of huntington's disease, EMBO J., 31, 1853, 10.1038/emboj.2012.65 · DOI · Paper page
  13. Damiano, 2013, A role of mitochondrial complex II defects in genetic models of huntington's disease expressing N-terminal fragments of mutant huntingtin, Hum. Mol. Genet., 22, 3869, 10.1093/hmg/ddt242 · DOI · Paper page
  14. Diedrich, 2011, Brain region specific mitophagy capacity could contribute to selective neuronal vulnerability in Parkinson's disease, Proteome Sci., 9, 59, 10.1186/1477-5956-9-59 · DOI · Paper page
  15. Dubinsky, 2009, Heterogeneity of nervous system mitochondria: location, location, location!, Exp. Neurol., 218, 293, 10.1016/j.expneurol.2009.05.020 · DOI
  16. DuBoff, 2013, Why size matters — balancing mitochondrial dynamics in Alzheimer's disease, Trends Neurosci., 36, 325, 10.1016/j.tins.2013.03.002 · DOI · Paper page
  17. Ehrlich, 2012, Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease, Neurotherapeutics, 9, 270, 10.1007/s13311-012-0112-2 · DOI · Paper page
  18. Fimia, 2007, Ambra1 regulates autophagy and development of the nervous system, Nature, 447, 1121, 10.1038/nature05925 · DOI · Paper page
  19. Francelle, 2014, Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in huntington's disease, Front. Cell. Neurosci., 8, 295, 10.3389/fncel.2014.00295 · DOI · Paper page
  20. Fu, 2014, LC3 binding to the scaffolding protein JIP1 regulates processive dynein-driven transport of autophagosomes, Dev. Cell, 29, 577, 10.1016/j.devcel.2014.04.015 · DOI · Paper page
  21. Guedes-Dias, 2015, HDAC6 inhibition induces mitochondrial fusion, autophagic flux and reduces diffuse mutant huntingtin in striatal neurons, Biochim. Biophys. Acta, 1852, 2484, 10.1016/j.bbadis.2015.08.012 · DOI
  22. Guedes-Dias, 2013, Lysine deacetylases and mitochondrial dynamics in neurodegeneration, Biochim. Biophys. Acta, 1832, 1345, 10.1016/j.bbadis.2013.04.005 · DOI
  23. Guo, 2013, Inhibition of mitochondrial fragmentation diminishes huntington's disease-associated neurodegeneration, J. Clin. Invest., 123, 5371, 10.1172/JCI70911 · DOI · Paper page
  24. Harbauer, 2014, The protein import machinery of mitochondria-a regulatory hub in metabolism, stress, and disease, Cell Metab., 19, 357, 10.1016/j.cmet.2014.01.010 · DOI · Paper page
  25. Haun, 2013, S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in huntington's disease, Antioxid. Redox Signal., 19, 1173, 10.1089/ars.2012.4928 · DOI · Paper page
  26. HDCRG, 1993, A novel gene containing a trinucleotide repeat that is expanded and unstable on huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group, Cell, 72, 971, 10.1016/0092-8674(93)90585-E · DOI · Paper page
  27. Her, 2008, Enhanced sensitivity of striatal neurons to axonal transport defects induced by mutant huntingtin, J. Neurosci, 28, 13662, 10.1523/JNEUROSCI.4144-08.2008 · DOI · Paper page
  28. Hering, 2015, Selective striatal mtDNA depletion in end-stage huntington's disease R6/2 mice, Exp. Neurol., 266, 22, 10.1016/j.expneurol.2015.02.004 · DOI
  29. Hinckelmann, 2013, Releasing the brake: restoring fast axonal transport in neurodegenerative disorders, Trends Cell Biol., 23, 634, 10.1016/j.tcb.2013.08.007 · DOI
  30. Johri, 2013, PGC-1alpha, mitochondrial dysfunction, and huntington's disease, Free Radic. Biol. Med., 62, 37, 10.1016/j.freeradbiomed.2013.04.016 · DOI · Paper page
  31. Jonas, 2014, Impaired import: how huntingtin harms, Nat. Neurosci., 17, 747, 10.1038/nn.3726 · DOI
  32. Kanki, 2015, Mitophagy in yeast: Molecular mechanisms and physiological role, Biochim. Biophys. Acta, 10.1016/j.bbamcr.2015.01.005 · DOI
  33. Khalil, 2015, PINK1-induced mitophagy promotes neuroprotection in huntington's disease, Cell Death Dis., 6, e1617, 10.1038/cddis.2014.581 · DOI · Paper page
  34. Kim, 2010, Mitochondrial loss, dysfunction and altered dynamics in huntington's disease, Hum. Mol. Genet., 19, 3919, 10.1093/hmg/ddq306 · DOI · Paper page
  35. Kuta, 2010, Mouse cytoplasmic dynein intermediate chains: identification of new isoforms, alternative splicing and tissue distribution of transcripts, PLoS ONE, 5, 10.1371/annotation/59badad8-6e55-46f8-8bf1-7a8a957bc68e · doi:10.1371/annotation/59badad8-6e55-46f8-8bf1-7a8a957bc68e
  36. Kuznetsov, 2009, The cell-type specificity of mitochondrial dynamics, Int. J. Biochem. Cell Biol., 41, 1928, 10.1016/j.biocel.2009.03.007 · DOI · Paper page
  37. Le Grand, 2013, Specific distribution of the autophagic protein GABARAPL1/GEC1 in the developing and adult mouse brain and identification of neuronal populations expressing GABARAPL1/GEC1, PLoS ONE, 8, 10.1371/journal.pone.0063133 · DOI · Paper page
  38. Lee, 2011, Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy, J. Neurosci., 31, 7817, 10.1523/JNEUROSCI.6412-10.2011 · DOI · Paper page
  39. Leitão-Rocha, 2015, Trends in mitochondrial therapeutics for neurological disease, Curr. Med. Chem., 22, 2458, 10.2174/0929867322666150209160317 · DOI
  40. Li, 1995, A huntingtin-associated protein enriched in brain with implications for pathology, Nature, 378, 398, 10.1038/378398a0 · DOI · Paper page
  41. Liot, 2013, Mutant huntingtin alters retrograde transport of TrkB receptors in striatal dendrites, J. Neurosci., 33, 6298, 10.1523/JNEUROSCI.2033-12.2013 · DOI · Paper page
  42. MacAskill, 2010, Control of mitochondrial transport and localization in neurons, Trends Cell Biol., 20, 102, 10.1016/j.tcb.2009.11.002 · DOI · Paper page
  43. Margulis, 2014, Proteostasis in striatal cells and selective neurodegeneration in Huntington's disease, Front. Cell. Neurosci., 8, 218, 10.3389/fncel.2014.00218 · DOI · Paper page
  44. Meisinger, 2008, The mitochondrial proteome: from inventory to function, Cell, 134, 22, 10.1016/j.cell.2008.06.043 · DOI
  45. Mishra, 2014, Mitochondrial dynamics and inheritance during cell division, development and disease, Nat. Rev. Mol. Cell Biol., 15, 634, 10.1038/nrm3877 · DOI · Paper page
  46. Ney, 2015, Mitochondrial autophagy: origins, significance, and role of BNIP3 and NIX, Biochim. Biophys. Acta, 1853, 2775, 10.1016/j.bbamcr.2015.02.022 · DOI · Paper page
  47. Oliveira, 2010, Mitochondrial bioenergetics and dynamics in Huntington's disease: tripartite synapses and selective striatal degeneration, J. Bioenerg. Biomembr., 42, 227, 10.1007/s10863-010-9287-6 · DOI
  48. Oliveira, 2010, Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum, J. Neurochem., 114, 1, 10.1111/j.1471-4159.2010.06741.x · DOI · Paper page
  49. Oliveira, 2011, Techniques to investigate neuronal mitochondrial function and its pharmacological modulation, Curr. Drug Targets, 12, 762, 10.2174/138945011795528895 · DOI
  50. Oliveira, 2006, Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors, J. Neurosci., 26, 11174, 10.1523/JNEUROSCI.3004-06.2006 · DOI · Paper page
  51. Oliveira, 2009, In situ mitochondrial Ca2+ buffering differences of intact neurons and astrocytes from cortex and striatum, J. Biol. Chem., 284, 5010, 10.1074/jbc.M807459200 · DOI · Paper page
  52. Oliveira, 2010, Could successful (mitochondrial) networking help prevent Huntington's disease?, EMBO Mol. Med., 2, 487, 10.1002/emmm.201000104 · DOI
  53. Orr, 2008, N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking, J. Neurosci., 28, 2783, 10.1523/JNEUROSCI.0106-08.2008 · DOI · Paper page
  54. Otera, 2011, Molecular mechanisms and physiologic functions of mitochondrial dynamics, J. Biochem., 149, 241, 10.1093/jb/mvr002 · DOI · Paper page
  55. Pagliarini, 2008, A mitochondrial protein compendium elucidates complex I disease biology, Cell, 134, 112, 10.1016/j.cell.2008.06.016 · DOI · Paper page
  56. Paulsen, 2010, Striatal and white matter predictors of estimated diagnosis for Huntington disease, Brain Res. Bull., 82, 201, 10.1016/j.brainresbull.2010.04.003 · DOI · Paper page
  57. Pickrell, 2011, The striatum is highly susceptible to mitochondrial oxidative phosphorylation dysfunctions, J. Neurosci., 31, 9895, 10.1523/JNEUROSCI.6223-10.2011 · DOI · Paper page
  58. Plotkin, 2015, Corticostriatal synaptic adaptations in Huntington's disease, Curr. Opin. Neurobiol., 33C, 53, 10.1016/j.conb.2015.01.020 · DOI · Paper page
  59. Puddifoot, 2012, PGC-1alpha negatively regulates extrasynaptic NMDAR activity and excitotoxicity, J. Neurosci, .32, 6995, 10.1523/JNEUROSCI.6407-11.2012 · DOI · Paper page
  60. Qi, 2013, A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity, J. Cell Sci., 126, 789, 10.1242/jcs.114439 · DOI · Paper page
  61. Reddy, 2012, Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease, Biochim. Biophys. Acta, 1822, 101, 10.1016/j.bbadis.2011.10.016 · DOI · Paper page
  62. Ross, 2011, Huntington's disease: from molecular pathogenesis to clinical treatment, Lancet Neurol., 10, 83, 10.1016/S1474-4422(10)70245-3 · DOI · Paper page
  63. Schulz, 2015, Unlocking the presequence import pathway, Trends Cell Biol., 25, 265, 10.1016/j.tcb.2014.12.001 · DOI · Paper page
  64. Seneca, 2004, Early onset Huntington disease: a neuronal degeneration syndrome, Eur. J. Pediatr., 163, 717, 10.1007/s00431-004-1537-3 · DOI
  65. Sepe, 2014, Expression of Ambra1 in mouse brain during physiological and Alzheimer type aging, Neurobiol. Aging, 35, 96, 10.1016/j.neurobiolaging.2013.07.001 · DOI · Paper page
  66. Sepers, 2014, Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease, Drug Discov. Today, 19, 990, 10.1016/j.drudis.2014.02.006 · DOI
  67. Shi, 2014, BNIP3 interacting with LC3 triggers excessive mitophagy in delayed neuronal death in stroke, CNS Neurosci. Ther., 20, 1045, 10.1111/cns.12325 · DOI · Paper page
  68. Shirendeb, 2011, Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage, Hum. Mol. Genet., 20, 1438, 10.1093/hmg/ddr024 · DOI · Paper page
  69. Shirendeb, 2012, Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease, Hum. Mol. Genet., 21, 406, 10.1093/hmg/ddr475 · DOI · Paper page
  70. Smirnova, 2001, Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells, Mol. Biol. Cell, 12, 2245, 10.1091/mbc.12.8.2245 · DOI · Paper page
  71. Song, 2011, Mutant Huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity, Nat. Med., 17, 377, 10.1038/nm.2313 · DOI · Paper page
  72. Subramaniam, 2009, Rhes, a striatal specific protein, mediates mutant-Huntingtin cytotoxicity, Science, 324, 1327, 10.1126/science.1172871 · DOI · Paper page
  73. Walker, 2007, Huntington's disease, Lancet, 369, 218, 10.1016/S0140-6736(07)60111-1 · DOI · Paper page
  74. Wang, 2011, PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility, Cell, 147, 893, 10.1016/j.cell.2011.10.018 · DOI · Paper page
  75. Wong, 2014, The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation, J. Neurosci., 34, 1293, 10.1523/JNEUROSCI.1870-13.2014 · DOI · Paper page
  76. Xiang, 2014, Huntingtin-associated protein 1 regulates postnatal neurogenesis and neurotrophin receptor sorting, J. Clin. Invest., 124, 85, 10.1172/JCI69206 · DOI
  77. Yano, 2014, Inhibition of mitochondrial protein import by mutant huntingtin, Nat. Neurosci., 17, 822, 10.1038/nn.3721 · DOI · Paper page
  78. Yu, 2003, Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease, J. Neurosci., 23, 2193, 10.1523/JNEUROSCI.23-06-02193.2003 · DOI · Paper page
  79. Zhang, 2014, Tubastatin A/ACY-1215 improves cognition in Alzheimer's disease transgenic mice, J. Alzheimers Dis., 41, 1193, 10.3233/JAD-140066 · DOI · Paper page
  80. Zuccato, 2007, Role of brain-derived neurotrophic factor in Huntington's disease, Prog. Neurobiol., 81, 294, 10.1016/j.pneurobio.2007.01.003 · DOI · Paper page

Cited by

Metadata

Authors
Guedes-Dias, P., Pinho, B. R., Soares, T. R., de Proença, J., Duchen, M. R., & Oliveira, J. M. A.
Venue
Neurobiology of Disease
Publisher
Elsevier BV
Published
2016-06
Volume
90
Pages
51-57
ISSN
0969-9961
Cited by
113
References
29
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • Fundação para a Ciência e a Tecnologia (FCT): (UID/QUI/50006/2013, PTDC/NEU-NMC/0237/2012)
  • European Union (FEDER, QREN, COMPETE) (FCOMP-01-0124-FEDER-029649)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.